A pharmaceutical company faced hurdles when a label change for a key drug introduced new prior authorization requirements, creating confusion and delays for patients, prescribers, and payers. Conduent, already managing the company’s patient access hub, quickly anticipated these challenges, tracked denial trends, and worked with providers to craft precise responses. Leveraging strong partnerships and expert analysis, Conduent overturned 91 percent of denials tied to the label change. The solution preserved timely access to therapy, improved patient outcomes, and demonstrated the value of proactive planning, effective communication, and targeted denials management.

Join for free to read